← Leaderboards
Jason Gien
University Of Colorado Denver
$661,500
Attributed
$661,500
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $132.3K · FY2010–14$200K$150K$100K$50K$0
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$661,500 · 1
By mechanism
K08$661,500 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Kurt R Stenmark$22,132,904
- Robin Shandas$12,521,834
- John P Kinsella$11,583,028
- James D West$14,128,198
- Mita Das$2,574,571
Others in their field
Top investigators on “Acute”
- Barton F Haynes · Duke University$295,684,085
- Peter C Adamson · National Childhood Cancer Foundation$256,842,224
- Judith S. Currier · University Of California Los Angeles$242,306,415
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$230,305,108
- Lawrence Corey · Fred Hutchinson Cancer Center$204,110,869
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
Research focus
AcuteAlveolarAngiogenesisAlabamaApplications GrantsAppointmentAwardBaseAnimalsBirthBlood CirculationBlood VesselsCareerCell GrowthCell PhysiologyCell ProliferationCellsCellular BiologyCesarean SectionChronicCoculture TechniquesCollaborationsColoradoComplex
Grant awards (5)
Rho-kinase signaling in lung development and persistent pulmonary hypertension$132,300
K08 · FY2014 · HL · contact PI
Rho-kinase signaling in lung development and persistent pulmonary hypertension$132,300
K08 · FY2013 · HL · contact PI
Rho-kinase signaling in lung development and persistent pulmonary hypertension$132,300
K08 · FY2012 · HL · contact PI
Rho-kinase signaling during normal lung development and in Persistent Pulmonary H$132,300
K08 · FY2011 · HL · contact PI
Rho-kinase signaling during normal lung development and in Persistent Pulmonary H$132,300
K08 · FY2010 · HL · contact PI